Literature DB >> 25819940

Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma.

Soo Young Kim1, Soo Nyung Kim2, Hyung Jin Hahn1, Yang Won Lee3, Yong Beom Choe4, Kyu Joong Ahn4.   

Abstract

BACKGROUND: BRAF mutations occur in some melanomas. We hypothesized that BRAF mutation rates may differ in melanomas found in Asian compared to white populations.
OBJECTIVE: We performed a metaanalysis of BRAF mutations and their associations with the clinicopathologic characteristics of primary melanoma (PM), with a subgroup analysis to compare Asian and white patients with PM.
METHODS: The PubMed, EMBASE, and Cochrane databases were searched up to November 2013. The incidence rates and odds ratios (ORs) of BRAF mutations were calculated using a fixed or random effects model.
RESULTS: BRAF mutation was associated with younger age (OR = 1.734; P < .001), trunk location (OR = 2.272; P < .001), non-chronically sun damaged skin (OR = 2.833; P < .001), superficial spreading melanoma (OR = 2.081; P < .001), and advanced melanoma stage (OR = 1.551; P = .003). The incidence of BRAF mutations in Asian patients with PM was half that of white patients with PM, but it was linked to the same clinicopathologic characteristics. LIMITATIONS: Only a small number of studies have been conducted on Asian patients with PMs.
CONCLUSIONS: The BRAF mutation in PM was associated with age, anatomic site based on ultraviolet radiation exposure, histologic subtype, and advanced stage of melanoma. The clinicopathologic associations with BRAF mutations were similar in Asian and white patients with PM.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asians; BRAF mutation; melanoma; metaanalysis; race; systematic review

Mesh:

Substances:

Year:  2015        PMID: 25819940     DOI: 10.1016/j.jaad.2015.02.1113

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

Review 1.  Diagnosis and Management of Acral Lentiginous Melanoma.

Authors:  Yoshiyuki Nakamura; Yasuhiro Fujisawa
Journal:  Curr Treat Options Oncol       Date:  2018-06-27

Review 2.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

3.  Melanoma Tumor Characteristics: An Analysis of Mutational Burden and Copy Number Alterations by Patient Age and Stage.

Authors:  Ruzica Z Conic; Joshua Arbesman
Journal:  J Invest Dermatol       Date:  2017-12-05       Impact factor: 8.551

Review 4.  KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma.

Authors:  Jonas Cicenas; Linas Tamosaitis; Kotryna Kvederaviciute; Ricardas Tarvydas; Gintare Staniute; Karthik Kalyan; Edita Meskinyte-Kausiliene; Vaidotas Stankevicius; Mindaugas Valius
Journal:  Med Oncol       Date:  2017-01-10       Impact factor: 3.064

Review 5.  Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma.

Authors:  Nika Filipović; Mirna Šitum; Marija Buljan
Journal:  Dermatol Pract Concept       Date:  2021-04-12

6.  Conjunctival Metastasis of a Cutaneous Melanoma.

Authors:  Niels J Brouwer; Marina Marinkovic; Anouk Jochems; Ellen W Kapiteijn; Sjoerd G van Duinen; Barbara I Haeseker; Martine J Jager; Gregorius P M Luyten
Journal:  Ocul Oncol Pathol       Date:  2017-09-01

Review 7.  Melanoma Epidemiology and Sun Exposure.

Authors:  Sara Raimondi; Mariano Suppa; Sara Gandini
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

8.  Tumour mutation status and sites of metastasis in patients with cutaneous melanoma.

Authors:  Nikki R Adler; Rory Wolfe; John W Kelly; Andrew Haydon; Grant A McArthur; Catriona A McLean; Victoria J Mar
Journal:  Br J Cancer       Date:  2017-08-08       Impact factor: 7.640

9.  Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?

Authors:  Stefano Guadagni; Giammaria Fiorentini; Marco Clementi; Giancarlo Palumbo; Paola Palumbo; Alessandro Chiominto; Stefano Baldoni; Francesco Masedu; Marco Valenti; Ambra Di Tommaso; Bianca Fabi; Camillo Aliberti; Donatella Sarti; Veronica Guadagni; Cristina Pellegrini
Journal:  Int J Mol Sci       Date:  2017-11-09       Impact factor: 5.923

Review 10.  Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients.

Authors:  Sarah Zhou; Daniel Sikorski; Honghao Xu; Andrei Zubarev; May Chergui; François Lagacé; Wilson H Miller; Margaret Redpath; Stephanie Ghazal; Marcus O Butler; Teresa M Petrella; Joël Claveau; Carolyn Nessim; Thomas G Salopek; Robert Gniadecki; Ivan V Litvinov
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.